(S013) Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
Oncology 30 Suppl
2016
ISSN/ISBN: 0890-9091 PMID: 27083682 Document Number: 686473
Document emailed within 1 workday
Related Documents
Aytekin, A.; Ciltas, A.; Sahinli, H.; Benekli, M. 2016: The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases Journal of BUON: Official Journal of the Balkan Union of Oncology 21(1): 281-282Jensen, R.L.; Shrieve, A.F.; Samlowski, W.; Shrieve, D.C. 2008: Outcomes of patients with brain metastases from melanoma and renal cell carcinoma after primary stereotactic radiosurgery Clinical Neurosurgery 55: 150-159
Nagai, M.; Oguma, H.; Arai, F.; Watanabe, E.; Nakazawa, M. 2014: Analysis of initial treatment only by linac-based stereotactic radiosurgery for a metastatic brain tumor from non-small cell lung cancer No Shinkei Geka. Neurological Surgery 42(4): 327-334
2015: (S049) salvage stereotactic radiosurgery for locally recurrent brain metastases treated previously with stereotactic radiosurgery Oncology 29(4 Suppl. 1)
2016: (P030) Efficacy of Stereotactic Radiosurgery (SRS) for Brain Metastases: Is There a Difference in Survival Between First and Second Brain Metastatic Event? Oncology 30 Suppl
Reddy, A.V.; Mills, M.N.; Liauw, S.L.; Baliga, S.; Kersh, C.R. 2019: Long term control and preservation of renal function after multiple courses of stereotactic body radiation therapy for renal cell carcinoma Canadian Journal of Urology 26(2): 9743-9745
Flickinger, J.C. 2000: Radiosurgery of brain metastases from renal cell carcinoma: how can you improve on results like this? Cancer Journal 6(6): 360-361
Bagadi, S.; Saikia, T.; Pany, A.; Das, B. 2011: Analysis of ABL Kinase Domain Mutations Conferring Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Cases from India Clinical Laboratory 57(7-8): 619-623
Fasika, O.M.; Shokunbi, M.T. 1996: Metastatic basal cell carcinoma of the spine Central African Journal of Medicine 42(3): 76-77
Müller, D.; Tomasović-Loncarić, C.; Galeic-Iljubanović, D.; Heinzl, R.; Savić, I.; Marusić, P. 2012: Renal cell carcinoma with concurrent urothelial carcinoma of urinary bladder and non-Hodgkin lymphoma Collegium Antropologicum 36(3): 1049-1052
Durocher, Y.; Chapdelaine, A.; Chevalier, S. 1989: Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145 Cancer Research 49(17): 4818-4823
Dutcher, J.P. 2011: High-dose interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma: still the standard Oncology 25(5): 427-428
Shepherd, F.A. 2016: Should EGFR tyrosine kinase inhibitors be used in non-small cell lung cancer in the absence of EGFR mutations? Yes, there is a role for EGFR TKIs in these patients Clinical Advances in Hematology and Oncology: H&o 14(1): 41-43
Miyata, H.; Sasaki, T.; Kuwahara, K.; Serikawa, M.; Chayama, K. 2006: The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines International Journal of Oncology 28(4): 915-921
Goldman, J. 2004: CML resistance to tyrosine kinase inhibitors: how is the laboratory to tell? Laboratory Hematology: Official Publication of the International Society for Laboratory Hematology 10(3): 181-184
Coşkun, F.; Cetinkaya, M.; Cengiz, O.; Adsan, O.; Kulaçoğlu, S.; Eroğlu, A. 1995: Metastatic carcinoma of the gallbladder due to renal cell carcinoma in the ectopic kidney Acta Chirurgica Belgica 95(1): 56-58
Sarma, D.P.; Wang, J.F.; McAllister, M.V.; Wang, B.; Shehan, J.M. 2008: Possible implantation carcinoma of the scalp following craniotomy for metastatic renal cell carcinoma Dermatology Online Journal 14(6): 20
Przytulska, J.; Tupikowski, K.; Bednarek-Tupikowska, G. 2014: Thyroid dysfunction in patients treated with tyrosine kinase inhibitors Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 36(211): 42-44
Pang, S.H.; Guo, Z.R.; Liang, X.T. 1997: Synthesis and biological activity of tyrosine protein kinase inhibitors Yao Xue Xue Bao 32(7): 515-523
Zhao, L.-d.; Li, J.-L.; Wang, Y.; Wang, B.; Wang, H.-Y.; Hao, X.-Z.; Cui, C.-X.; Zhang, X.-R.; Shi, Y.-K. 2011: Analysis of chemotherapeutic efficacy after a failed regimen of epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced non-small cell lung carcinoma Zhonghua Yi Xue Za Zhi 91(6): 366-369